[Adrenocortical carcinoma].
Ichikawa
T
T
Department of Molecular Oncology, Graduate School of Medicine, Chiba University.
Ito
H
H
D000306:Adrenal Cortex Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D000315:Adrenalectomy; D018268:Adrenocortical Carcinoma / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D000367:Age Factors; D003131:Combined Modality Therapy; D005260:Female; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics; D008297:Male; D008939:Mitotane / Q000627:therapeutic use; D009017:Morbidity; D009154:Mutation; D018043:Receptors, Corticotropin / Q000235:genetics; D012737:Sex Factors
D018043:Receptors, Corticotropin; D007335:Insulin-Like Growth Factor II; D008939:Mitotane